Literature DB >> 19430731

Subfoveal choroidal neovascularization in a patient with hemicentral vein occlusion.

Antonio Fea1, Andrea Grosso, Massimo Mollo, Federico M Grignolo.   

Abstract

The association between choroidal neovascularization (CNV) and retinal vein occlusive disease is uncommon. Before the introduction of anti-vascular endothelial growth factor (VEGF) drugs, photodynamic therapy (PDT) was used, with conflicting functional results. We report a case of a 69-year-old male patient who came to our attention for macular edema in hemiretinal vein occlusion. Fluorescein angiogram showed presence of venous collaterals, but the pattern of the edema was atypical; optical coherence tomography (OCT) and indocyanine green angiography (ICG) were used to confirm the diagnosis of CNV. A chorio-retinal shunt was demonstrated. The autofluorescence technique was used to predict the risk of CNV in the fellow eye. PDT was performed twice, but after the second cycle, patient developed choroidal ischemia and the visual outcomes were poor. The temporal course of CNV, the presence of a chorio-retinal shunt, and the autofluorescence pattern in the fellow eye let us to speculate that the CNV was related to the vascular occlusive process. We can speculate that the overexpression of VEGF induced by local ischemia and inflammation can make these patients more likely to have CNV. However, to our knowledge, there are no accurate estimates of the incidence of CNV in other retinal vascular diseases, such as diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19430731     DOI: 10.1007/s10792-009-9306-y

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  7 in total

1.  Photodynamic therapy for choroidal neovascularization in eyes with retinal vascular disorders.

Authors:  Chiara M Eandi; Felice Cardillo Piccolino; Luca Ventre; Federico M Grignolo
Journal:  Retina       Date:  2002-08       Impact factor: 4.256

2.  Choroidal neovascularization after central retinal vein occlusion in a 47-year-old man.

Authors:  David A DiLoreto; Morton F Goldberg; Neil M Bressler
Journal:  Arch Ophthalmol       Date:  2004-09

3.  Classification of fundus autofluorescence patterns in early age-related macular disease.

Authors:  Almut Bindewald; Alan C Bird; Samantha S Dandekar; Joanna Dolar-Szczasny; Jens Dreyhaupt; Frederick W Fitzke; Wilma Einbock; Frank G Holz; Jork J Jorzik; Claudia Keilhauer; Noemi Lois; Juliane Mlynski; Daniel Pauleikhoff; Giovanni Staurenghi; Sebastian Wolf
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-09       Impact factor: 4.799

4.  Photodynamic therapy with verteporfin for retinal angiomatous proliferation.

Authors:  Francesco Boscia; Maurizio Battaglia Parodi; Claudio Furino; Michele Reibaldi; Carlo Sborgia
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-09       Impact factor: 3.117

5.  Choroidal ischemia after photodynamic therapy with verteporfin for choroidal neovascularization.

Authors:  Vincenzo Isola; Alfredo Pece; Maurizio Battaglia Parodi
Journal:  Am J Ophthalmol       Date:  2006-10       Impact factor: 5.258

6.  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1999-10

7.  Chronic systemic hypoxia causes intra-retinal angiogenesis.

Authors:  Alex J Shortt; Katherine Howell; Colm O'Brien; Paul McLoughlin
Journal:  J Anat       Date:  2004-11       Impact factor: 2.610

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.